T. Rowe Price Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $854K | Buy |
49,308
+1,595
| +3% | +$27.6K | ﹤0.01% | 629 |
|
|
2025
Q1 | $1.04M | Hold |
47,713
| – | – | ﹤0.01% | 614 |
|
|
2024
Q4 | $1.52M | Sell |
47,713
-2,937,559
| -98% | -$93.8M | ﹤0.01% | 595 |
|
|
2024
Q3 | $86.1M | Sell |
2,985,272
-1,063,140
| -26% | -$30.7M | 0.05% | 323 |
|
|
2024
Q2 | $155M | Sell |
4,048,412
-557,309
| -12% | -$21.4M | 0.1% | 205 |
|
|
2024
Q1 | $271M | Sell |
4,605,721
-1,697,863
| -27% | -$99.8M | 0.17% | 154 |
|
|
2023
Q4 | $377M | Sell |
6,303,584
-215,887
| -3% | -$12.9M | 0.25% | 113 |
|
|
2023
Q3 | $248M | Buy |
6,519,471
+880,596
| +16% | +$33.5M | 0.18% | 152 |
|
|
2023
Q2 | $514M | Sell |
5,638,875
-121,789
| -2% | -$11.1M | 0.35% | 86 |
|
|
2023
Q1 | $380M | Sell |
5,760,664
-81,996
| -1% | -$5.41M | 0.27% | 102 |
|
|
2022
Q4 | $302M | Buy |
5,842,660
+326,537
| +6% | +$16.9M | 0.23% | 117 |
|
|
2022
Q3 | $377M | Buy |
+5,516,123
| New | +$377M | 0.3% | 94 |
|